Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 138 participants.
Also called NCT01407003
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose other
- Phase
- Phase 1/2
- Enrolled
- 138 participants
- Sponsor
- Registry
-
NCT01407003
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01407003. Randomized; double masking; primary purpose other. Start 2011-06 (registry gives no type); primary completion 2013-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)
- Condition
- Type 2 Diabetes Mellitus (T2DM)
- Intervention (Drug)
- LIK066
- Intervention (Drug)
- Placebo
- Lead sponsor
- Novartis Pharmaceuticals
Record details
- Record id
cardio:ct-nct01407003- Content hash
d3a8a48a9529f7cba0ccf0a2d9f97f3401cfda84b2d7d72a08cf379d8374c490